Sunshine Biopharma Warrant Stock Buy Hold or Sell Recommendation
| SBFMW Stock | USD 0.17 0.04 19.05% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding Sunshine Biopharma Warrant is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sunshine Biopharma Warrant given historical horizon and risk tolerance towards Sunshine Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Sunshine Biopharma Warrant, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Sunshine Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Sunshine Stock please use our How to Invest in Sunshine Biopharma guide. Note, we conduct extensive research on individual companies such as Sunshine and provide practical buy, sell, or hold advice based on investors' constraints. Sunshine Biopharma Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Sunshine |
Execute Sunshine Biopharma Buy or Sell Advice
The Sunshine recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sunshine Biopharma Warrant. Macroaxis does not own or have any residual interests in Sunshine Biopharma Warrant or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sunshine Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Sunshine Biopharma Trading Alerts and Improvement Suggestions
| Sunshine Biopharma is way too risky over 90 days horizon | |
| Sunshine Biopharma has some characteristics of a very speculative penny stock | |
| Sunshine Biopharma appears to be risky and price may revert if volatility continues | |
| Sunshine Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 24.09 M. Net Loss for the year was (4.51 M) with profit before overhead, payroll, taxes, and interest of 110.6 K. | |
| Sunshine Biopharma Warrant has accumulated about 40.56 M in cash with (8.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Sunshine Biopharma launches generic liver drug in Canada - Investing.com |
Sunshine Biopharma Returns Distribution Density
The distribution of Sunshine Biopharma's historical returns is an attempt to chart the uncertainty of Sunshine Biopharma's future price movements. The chart of the probability distribution of Sunshine Biopharma daily returns describes the distribution of returns around its average expected value. We use Sunshine Biopharma Warrant price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sunshine Biopharma returns is essential to provide solid investment advice for Sunshine Biopharma.
| Mean Return | 2.64 | Value At Risk | -28 | Potential Upside | 50.00 | Standard Deviation | 21.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sunshine Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sunshine Biopharma Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (74.7K) | 949.4K | 1.1M | 19.8M | (5.5M) | (5.3M) | |
| Free Cash Flow | (496.7K) | (658.5K) | (1.8M) | (5.6M) | (9.6M) | (9.1M) | |
| Other Non Cash Items | 1.2M | 2.2M | 10.7M | 18.3M | 4.6M | 3.7M | |
| Capital Expenditures | 18.9K | 860.0 | 1.2K | 305.0K | 788.1K | 827.5K | |
| Net Income | (1.7M) | (2.8M) | (12.4M) | (26.7M) | (4.5M) | (4.7M) | |
| End Period Cash Flow | 40.5K | 989.9K | 2.0M | 21.8M | 16.3M | 17.1M | |
| Depreciation | 13.8K | 14.1K | 12.7K | 25.2K | 149.1K | 156.6K | |
| Net Borrowings | 500.9K | 416.5K | 1.6M | 2.8M | 3.3M | 3.4M | |
| Change To Netincome | 1.5M | 1.2M | 2.2M | 10.7M | 12.3M | 12.9M | |
| Investments | (15.3K) | (1.2K) | (391.0) | (14.6M) | (15.0M) | (14.3M) |
Sunshine Biopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sunshine Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sunshine Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sunshine stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.33 | |
β | Beta against Dow Jones | 2.64 | |
σ | Overall volatility | 22.63 | |
Ir | Information ratio | 0.12 |
Sunshine Biopharma Volatility Alert
Sunshine Biopharma Warrant is showing large volatility of returns over the selected time horizon. Sunshine Biopharma Warrant is a potential penny stock. Although Sunshine Biopharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Sunshine Biopharma Warrant. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Sunshine instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Sunshine Biopharma Fundamentals Vs Peers
Comparing Sunshine Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sunshine Biopharma's direct or indirect competition across all of the common fundamentals between Sunshine Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sunshine Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sunshine Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sunshine Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sunshine Biopharma to competition |
| Fundamentals | Sunshine Biopharma | Peer Average |
| Return On Equity | -0.18 | -0.31 |
| Return On Asset | -0.11 | -0.14 |
| Profit Margin | (0.13) % | (1.27) % |
| Operating Margin | (0.13) % | (5.51) % |
| Number Of Shares Shorted | 4.18 K | 4.71 M |
| Revenue | 24.09 M | 9.43 B |
| Gross Profit | 110.6 K | 27.38 B |
| EBITDA | (3.82 M) | 3.9 B |
| Net Income | (4.51 M) | 570.98 M |
| Cash And Equivalents | 40.56 M | 2.7 B |
| Cash Per Share | 1.80 X | 5.01 X |
| Total Debt | 657.71 K | 5.32 B |
| Debt To Equity | 8.98 % | 48.70 % |
| Current Ratio | 85.09 X | 2.16 X |
| Book Value Per Share | 12.52 X | 1.93 K |
| Cash Flow From Operations | (8.78 M) | 971.22 M |
| Earnings Per Share | (2.21) X | 3.12 X |
| Number Of Employees | 44 | 18.84 K |
| Beta | -1.04 | -0.15 |
| Total Asset | 27.35 M | 29.47 B |
| Retained Earnings | (63.91 M) | 9.33 B |
| Working Capital | 19.34 M | 1.48 B |
| Net Asset | 27.35 M |
Note: Acquisition by Camille Sebaaly of 30000 shares of Sunshine Biopharma at 0.7635 subject to Rule 16b-3 [view details]
Sunshine Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sunshine . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Sunshine Biopharma Buy or Sell Advice
When is the right time to buy or sell Sunshine Biopharma Warrant? Buying financial instruments such as Sunshine Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sunshine Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Cap ETFs Thematic Idea Now
Large Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large Cap ETFs theme has 676 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.